<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2012.2161</article-id>
<article-id pub-id-type="publisher-id">or-29-02-0445</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>YOSHIZAWA</surname><given-names>KUNIO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-or-29-02-0445"/></contrib>
<contrib contrib-type="author">
<name><surname>NOZAKI</surname><given-names>SHINICHI</given-names></name><xref rid="af2-or-29-02-0445" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>KATO</surname><given-names>AKI</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>HIRAI</surname><given-names>MARIKO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>YANASE</surname><given-names>MIZUKI</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>YOSHIMOTO</surname><given-names>TAISUKE</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>KIMURA</surname><given-names>IYO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>SUGIURA</surname><given-names>SHIRO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>OKAMUNE</surname><given-names>AYAKO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>KITAHARA</surname><given-names>HIROKO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>NOGUCHI</surname><given-names>NATSUYO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>KATO</surname><given-names>KOROKU</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>UEKI</surname><given-names>KOICHIRO</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>KAWASHIRI</surname><given-names>SHUICHI</given-names></name><xref rid="af1-or-29-02-0445" ref-type="aff">1</xref></contrib></contrib-group>
<aff id="af1-or-29-02-0445">
<label>1</label>Department of Oral and Maxillofacial Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920-8641, Japan</aff>
<aff id="af2-or-29-02-0445">
<label>2</label>Department of Dentistry and Oral Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Ishikawa 920-8650, Japan</aff>
<author-notes>
<corresp id="c1-or-29-02-0445"><italic>Correspondence to:</italic> Dr Kunio Yoshizawa, Department of Oral and Maxillofacial Surgery, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan, E-mail: <email>yoshizawa@oral.m.kanazawa-u.ac.jp</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>11</month>
<year>2012</year></pub-date>
<volume>29</volume>
<issue>2</issue>
<fpage>445</fpage>
<lpage>450</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>08</month>
<year>2012</year></date>
<date date-type="accepted">
<day>02</day>
<month>11</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Claudin-7 belongs to the claudin family, which consists of 24 subtypes of essential tight junction (TJ) integral membrane proteins with molecular weights of 20&#x02013;27 kDa. We investigated the interrelationship between clinicopathological findings and claudin-7 expression in oral squamous cell carcinoma (OSCC). Using immunohistochemical techniques to examine the expression levels of claudin-7 in 67 cases of OSCC, claudin-7 expression was detected in 35 (52.2&#x00025;) of the 67 cases. We also compared the clinicopathological features of the OSCC cases with claudin-7 expression levels. Moreover, six cell lines with various invasive properties were investigated <italic>in vitro</italic> to compare mRNA and protein levels of claudin-7 using reverse transcription-polymerase chain reaction (RT-PCR) and the western blotting method. Decreased claudin-7 expression correlated significantly with T-category (p&lt;0.05), lymph node metastasis (p&lt;0.01), and mode of invasion (p&lt;0.001). Patients with positive claudin-7 expression had a significantly better prognosis (p&lt;0.05). Claudin-7 protein and mRNA levels were lower in the HOC313 and TSU cells, which have higher invasive potentials compared with other cell lines. These results suggest that loss of claudin-7 expression is associated closely with invasion and lymph metastasis and is an unfavorable prognostic factor in patients with OSCC.</p></abstract>
<kwd-group>
<kwd>carcinoma</kwd>
<kwd>tight junctions</kwd>
<kwd>prognosis</kwd>
<kwd>epithelial to mesenchymal transition</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Claudin family consists of 24 subtypes of essential tight junction (TJ) integral membrane proteins that have molecular weights of 20&#x02013;27 kDa and contain four transmembrane domains (<xref rid="b1-or-29-02-0445" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-or-29-02-0445" ref-type="bibr">3</xref>). Tight junctions are responsible for the formation and maintenance of the permeability barrier in polarized epithelial cells. The gene has subsequently been localized to epithelial cells in a variety of tissues, including oral squamous epithelium, and its protein shows tissue-specific distribution patterns (<xref rid="b4-or-29-02-0445" ref-type="bibr">4</xref>&#x02013;<xref rid="b6-or-29-02-0445" ref-type="bibr">6</xref>). It has become clear that, in addition to having tissue- and cell-specific features, modification or loss of these dynamic structures contributes to cancerization (<xref rid="b7-or-29-02-0445" ref-type="bibr">7</xref>&#x02013;<xref rid="b10-or-29-02-0445" ref-type="bibr">10</xref>). However, how the role of claudin-7 contributes to cancerization in squamous cell carcinoma remains to be elucidated, and the patterns of claudin-7 expression in carcinoma vary as shown below (<xref rid="b3-or-29-02-0445" ref-type="bibr">3</xref>,<xref rid="b11-or-29-02-0445" ref-type="bibr">11</xref>&#x02013;<xref rid="b18-or-29-02-0445" ref-type="bibr">18</xref>). Loss of claudin-7 has been reported to correlate with a poor prognosis in esophageal, colorectal, and nasopharyngeal cancers (<xref rid="b3-or-29-02-0445" ref-type="bibr">3</xref>,<xref rid="b11-or-29-02-0445" ref-type="bibr">11</xref>&#x02013;<xref rid="b14-or-29-02-0445" ref-type="bibr">14</xref>). On other hand, upregulation of claudin-7 has been reported to correlate with poor prognosis of carcinogenesis in ovarian, breast, and gastric carcinomas (<xref rid="b15-or-29-02-0445" ref-type="bibr">15</xref>&#x02013;<xref rid="b18-or-29-02-0445" ref-type="bibr">18</xref>).</p>
<p>The TNM classification which was proposed by the Union Internationale Contre le Cancer (UICC) (<xref rid="b19-or-29-02-0445" ref-type="bibr">19</xref>) is a good system for describing the condition of cancer patients. However, this system cannot predict the biological characteristics of tumor cells. It is there therefore important to look for new objective prognostic factors that provide additional information on the biological characteristics of tumors. It is believed that invasion and metastasis are the most crucial characteristics of malignant tumors. Thus, mode of invasion is used as a histopathological classification category in oral squamous cell carcinoma (OSCC), as described by Yamamoto <italic>et al</italic>(<xref rid="b20-or-29-02-0445" ref-type="bibr">20</xref>), and this classification is frequently used to predict progression, metastasis and prognosis (<xref rid="b20-or-29-02-0445" ref-type="bibr">20</xref>&#x02013;<xref rid="b25-or-29-02-0445" ref-type="bibr">25</xref>) (<xref rid="tI-or-29-02-0445" ref-type="table">Table I</xref>). To provide proper treatment, it is also important to examine the characteristics of cancer cells at the invasive front of OSCC.</p>
<p>We examined immunohistochemically the expression of claudin-7 <italic>in vivo</italic> and compared its expression in cell lines derived from invasive OSCC <italic>in vitro</italic> to investigate the interrelationship between clinicopathological factors including criteria on mode of invasion and claudin-7 expression in OSCC.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Specimens</title>
<p>Sixty-seven biopsy specimens of primary OSCC were obtained from patients undergoing surgical resection at the Department of Oral and Maxillofacial Surgery, Kanazawa University Hospital between 1989 and 2009. The patients (38 male and 29 female subjects) ranged in age from 32 to 91 years (mean age: 60 years). Informed consent for experimental use of the samples was obtained from the patients according to the hospital&#x02019;s ethical guidelines.</p></sec>
<sec>
<title>Staining methods</title>
<p>Immunohistochemical staining was performed by the labeled streptavidin-biotin (LSAB) method after deparaffinization and rehydration as described by Nozaki <italic>et al</italic>(<xref rid="b25-or-29-02-0445" ref-type="bibr">25</xref>). The sections were reacted with the following primary antibodies: anti-claudin-7 monoclonal antibody (Invitrogen Corp., Camarillo, CA, USA) diluted 200-fold with PBS at 4&#x000B0;C overnight. Sections were then reacted with a secondary antibody, biotin-labeled goat anti-rabbit immunoglobulin polyclonal antibody (Dako Japan, Kyoto, Japan) at RT for 60 min. A section of normal oral epithelium previously identified as strong staining was used as a positive control with each batch. As a negative control, PBS treated sections instead of claudin-7 antibody was used.</p></sec>
<sec>
<title>Cell culture and cell lines</title>
<p>All cell lines were maintained at 37&#x000B0;C in a humidified incubator containing 5&#x00025; CO<sub>2</sub>. The OSCC cell lines HSC-4, OSC-20, OSC-19, OTC-04, HOC313 and TSU were maintained in minimal essential medium (MEM; Sigma-Aldrich, Ayrshire, UK) supplemented with 10&#x00025; fetal bovine serum and 1&#x00025; penicillin-streptomycin. The cell lines were derived from OSCC with the following grades of invasiveness, according to the Yamamoto-Kohama criteria (<xref rid="b20-or-29-02-0445" ref-type="bibr">20</xref>): HSC-4 and OSC-20 cells from grade 3 as described for the low invasive type; OSC-19 and OTC-04 from grade 4C, as described for the mild invasive type; HOC313 and TSU from 4D as described for the high invasive types.</p></sec>
<sec>
<title>RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR)</title>
<p>RT-PCR analysis was performed using a modified method by Conboy <italic>et al</italic>(<xref rid="b26-or-29-02-0445" ref-type="bibr">26</xref>). RNA was extracted from cultured cells using an RNeasy kit (Qiagen, Hilden, Germany). A 1-&#x003BC;g sample in 10 &#x003BC;l of RNase free water was incubated for 5 min at 60&#x000B0;C and then quickly chilled on ice for 5 min. The RNA samples were reversed-transcribed into first-strand cDNA at 40&#x000B0;C for 40 min in RT solution from the RNeasy kit. The cDNA samples were amplified following addition of the PCR mixture solution and the following primers for claudin-7, 5&#x02032;-aat gta cga ctc ggt gct cg-3&#x02032; (forward) and 5&#x02032;-att ccc agg aca gga aca gg-3&#x02032; (reverse); for E-cadherin, 5&#x02032;-agc cat ggg ccc ttg gag-3&#x02032; (forward) and 5&#x02032;-cca gag gct ctg tca cct tc-3&#x02032; (reverse); for Snail, 5&#x02032;-acc act atg ccg cgc tct ttc ctc g-3&#x02032; (forward) and 5&#x02032;-gac agg aga agg gct tct cgc cag t-3&#x02032; (reverse) and for &#x003B2;-actin, 5&#x02032;-gaa aat ctg gca cca cac ctt-3&#x02032; (forward) and 5&#x02032;-ttg aag gta gtt tcg tgg at-3&#x02032; (reverse). PCRs were carried out under the following conditions: 3 min at 94&#x000B0;C, followed by cycles (30 for claudin-7, 30 for E-cadherin, 30 for Snail and 20 for &#x003B2;-actin) of 1 min at 94&#x000B0;C, 1 min at 58&#x000B0;C, and 1 min at 72&#x000B0;C. All reactions were completed with a final incubation at 72&#x000B0;C for 10 min. The lengths for the amplified fragments for claudin-7, E-cadherin, Snail and &#x003B2;-actin genes were 288, 544, 637 and 592 bp, respectively. PCR products were detected by 3.0&#x00025; agarose gel electrophoresis and staining with ethidium bromide.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Cultured cells on 80&#x00025; confluent plates were used for protein samples. The protein samples (30 &#x003BC;g) that were extracted from the whole cellular structure using M-PER (Mammalian protein extraction reagent) (Pierce, Rockford, IL, USA) were heated at 95&#x000B0;C for 5 min before electrophoresis and then subjected to 10&#x00025; SDS-PAGE. After electrophoresis, the samples were transferred onto PVDF membranes (ATTO Co., Tokyo, Japan) and incubated for 1 h with 200-fold diluted polyclonal anti-rabbit antibody against claudin-7 (Invitrogen, Carlsbad, CA, USA), a 2,000-fold diluted polyclonal anti-mouse antibody against E-cadherin (BD Biosciences, San Jose, CA, USA), a polyclonal anti-rabbit antibody against Snail (Abgent, San-Diego, CA, USA) and 5000-fold diluted polyclonal anti-mouse antibody &#x003B2;-actin (Sigma, St. Louis, MO, USA) respectively. The membrane was washed three times with PBS and then incubated for 1 h with 2000-fold diluted horseradish peroxidase-conjugated anti-rabbit IgG (Amersham, Buckinghamshire, UK) to detect claudin-7 and Snail, 2000-fold diluted horseradish peroxidase-conjugated anti-mouse IgG (Amersham) to detect E-cadherin and &#x003B2;-actin, respectively. The blots were revealed by enhanced chemiluminescent detection carried out according to the manufacturer&#x02019;s recommendations.</p></sec>
<sec>
<title>Assessment of immunohistochemical staining of claudin-7 proteins</title>
<p>Statistical analysis was performed with the SPSS for window version 16.0 (SPSS Inc., Chicago, IL, USA). The expression of claudin-7 in tumor cells was evaluated as present or absent. Only cases in which at least 25&#x00025; of the tumor cells were immunoreactive were scored as positive. The Mann-Whitney&#x02019;s U test and &#x003C7;<sup>2</sup> test were used to analyze the association of claudin-7 expression with clinicopathological factors. Survival rates of claudin-7 -positive and -negative patients were calculated by the Kaplan-Meyer method, and examined for statistical significance using the log-rank test. Differences were considered significant at p-values of &lt;0.05. Uni- and multi-variate analyses for the 5-year overall survival of individual parameters were performed.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Immunohistochemistry and evaluation</title>
<p>The relationship between the clinicopathological parameters and expression of claudin-7 is summarized in <xref rid="tII-or-29-02-0445" ref-type="table">Table II</xref>. Claudin-7 immunostaining was observed especially in membranes including the cytoplasm and nucleus of tumor cells (<xref rid="f1-or-29-02-0445" ref-type="fig">Fig. 1</xref>). Immunohistochemical staining showed that 35 specimens (52.2&#x00025;) were positive for claudin-7. There was a significant negative correlation between claudin-7 and T-category (p&lt;0.05), Lymph node metastasis (p&lt;0.01) and mode of invasion (p&lt;0.001); the number of claudin-7 positive cases were 11 (91.7&#x00025;) for grade 1, 12 (75.0&#x00025;) for grade 2, 9 (52.9&#x00025;) for grade 3, 3 (18.8&#x00025;) for grade 4C, and 0 (0&#x00025;) for grade 4D. Moreover, the number of claudin-7-positive cases was 5 (26.3&#x00025;) with lymph node metastasis and 30 (62.5&#x00025;) without lymph node metastasis. Therefore, claudin-7 expression showed a negative correlation with lymph node metastasis (p&lt;0.01). The overall 5 year-survival rate was 77.1&#x00025; in patients showing claudin-7 expression and 59.4&#x00025; in patients without claudin-7 expression (P&lt;0.05) (<xref rid="f2-or-29-02-0445" ref-type="fig">Fig. 2</xref>). <xref rid="tIII-or-29-02-0445" ref-type="table">Table III</xref> summarizes the univariate and multivariate analyses of the correlation between the clinicopathological and immunohistochemical variables, with respect to overall survival. Multivariate analysis revealed that only the 3-4D mode of invasion was significant and independent variables with relative risks of 7.44, although univariate analysis revealed that T-category, N-category, Cell differentiation, mode of invasion, expression of claudin-7 were also significant variables.</p></sec>
<sec>
<title>Analysis of claudin-7 mRNA, Snail and E-cadherin levels in OSCC cell lines by RT-PCR</title>
<p>We further examined the levels of claudin-7 mRNAs, E-cadherin and Snail in six cell lines by RT-PCR. Expressions of claudin-7 and E-cadherin were significantly lower in the HOC313 cells and TSU cells (grade 4D) while expression of Snail was higher in grade 4D than in the other cell lines (<xref rid="f3-or-29-02-0445" ref-type="fig">Fig. 3</xref>).</p></sec>
<sec>
<title>Analysis of claudin-7, Snail, E-cadherin protein levels in OSCC cell lines by western blotting</title>
<p>The expression of claudin-7 and E-cadherin protein was significantly lower in the HOC313 and TSU cell lines (grade 4D) while the expression of Snail was approximately consistent with the other cell lines (<xref rid="f4-or-29-02-0445" ref-type="fig">Fig. 4</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Oral squamous cell carcinoma is characterized by a high degree of invasion into local tissue, as well as high incidence of lymph node metastasis. However, there have been few reports on the association between the expression of claudin-7 and the invasive potential in OSCC. In this study, multivariate analysis revealed that only mode of invasion in 3-4D was significant. In addition, independent variables with relative risks of 7.44 were significant variables. However, univariate analysis revealed that T-category, N-category, cell differentiation, mode of invasion, and expression of claudin-7 were also significant. Even if limited to head and neck squamous cell carcinoma, how the pattern of claudin-7 expression correlates with invasion and metastasis is controversial. For example, Louren&#x000E7;o <italic>et al</italic>(<xref rid="b1-or-29-02-0445" ref-type="bibr">1</xref>) reported that loss of claudin-7 is associated with the pathogenesis and a poor prognosis. On the other hand Bello <italic>et al</italic>(<xref rid="b27-or-29-02-0445" ref-type="bibr">27</xref>) stated that medium immunoreactivity of claudin-7 tends to be associated with improved survival compared with strong and low immunoreactivity. This study showed that as the invasiveness of OSCC increased, the expression of claudin-7 became weaker, while studies on Snail, which reported on the suppression of E-cadherin and claudin, showed stronger expression in the most invasive mode type 4D, which has the characteristics of EMT such as spindly shape and decreased expression of E-cadherin (<xref rid="b23-or-29-02-0445" ref-type="bibr">23</xref>,<xref rid="b28-or-29-02-0445" ref-type="bibr">28</xref>).</p>
<p>Epithelial-mesenchymal transition (EMT) is one of the mechanisms by which epithelial cells acquire the motile properties required for invasion. Acquisition of the mesenchymal state, with fibroblastic phenotype, is accompanied by E-cadherin downregulation and upregulation of mesenchymal markers such as Snail, enabling cells to dissociate from the epithelial tissue and migrate (<xref rid="b29-or-29-02-0445" ref-type="bibr">29</xref>). An inverse correlation between Snail and E-cadherin expression has been reported in many types of cancers including squamous cell carcinoma (<xref rid="b30-or-29-02-0445" ref-type="bibr">30</xref>). Snail binds to E-boxes present in the E-cadherin promoter, consequently repressing E-cadherin transcription (<xref rid="b28-or-29-02-0445" ref-type="bibr">28</xref>&#x02013;<xref rid="b31-or-29-02-0445" ref-type="bibr">31</xref>). In addition, induction of Snail expression causes loss of TJ integral membrane proteins such as claudin by a similar mechanism (<xref rid="b6-or-29-02-0445" ref-type="bibr">6</xref>,<xref rid="b31-or-29-02-0445" ref-type="bibr">31</xref>). Accordingly, Snail may functions as an effector for EMT, and it enhances the invasive capacity of squamous cell carcinoma through the regulation of proteolytic enzymes, including claudin-7 in the course of EMT.</p>
<p>It is difficult to determine the difference between the grade 4C type and the grade 4D type. As such, the diagnostic criteria are based solely on histopathological findings and this has created unevenness in judgments between institutions in Japan. Diagnosis may be facilitated by applying the expression of adhesion targets such as claudin-7 and E-cadherin, and the expression of Snail to discriminate grade 4C from grade 4D. Moreover, new identification criteria of grade 4D that include evaluation of the property of adhesion and EMT may enhance the precision of the YK criteria as a prognosis marker and contribute beneficially to the development of strategies for OSCC treatment.</p>
<p>In conclusion, claudin-7 may be a useful marker to identify the potential for progression with a central focus on invasion in OSCC. It is necessary to clarify the mechanism between claudin-7 expression and the process of malignant progression of OSCC though continued research and its clinical application.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank all the members of our department for their helpful suggestions and support. This study was supported by a Grant-in-Aid for Scientific Research (no. 24792194) from the Ministry of Education, Science, Sports and Culture of Japan.</p></ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="G1">OSCC</term>
<def>
<p>oral squamous cell carcinoma</p></def></def-item>
<def-item>
<term id="G2">RT-PCR</term>
<def>
<p>reverse transcription-polymerase chain reaction</p></def></def-item>
<def-item>
<term id="G3">TJ</term>
<def>
<p>tight junction</p></def></def-item>
<def-item>
<term id="G4">UICC</term>
<def>
<p>Union International Contre le Cancer</p></def></def-item>
<def-item>
<term id="G5">LSAB</term>
<def>
<p>labeled streptavidin-biotin</p></def></def-item>
<def-item>
<term id="G6">EMT</term>
<def>
<p>epithelial-mesenchymal transition</p></def></def-item></def-list></glossary>
<ref-list>
<title>References</title>
<ref id="b1-or-29-02-0445"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louren&#x000E7;o</surname><given-names>SV</given-names></name><name><surname>Coutinho-Camillo</surname><given-names>CM</given-names></name><name><surname>Buim</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma</article-title><source>Histopathology</source><volume>57</volume><fpage>689</fpage><lpage>698</lpage><year>2010</year></element-citation></ref>
<ref id="b2-or-29-02-0445"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>H</given-names></name><name><surname>Hoggard</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name></person-group><article-title>Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway</article-title><source>Exp Cell Res</source><volume>317</volume><fpage>1935</fpage><lpage>1946</lpage><year>2011</year></element-citation></ref>
<ref id="b3-or-29-02-0445"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lioni</surname><given-names>M</given-names></name><name><surname>Brafford</surname><given-names>P</given-names></name><name><surname>Andl</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells</article-title><source>Am J Pathol</source><volume>170</volume><fpage>709</fpage><lpage>721</lpage><year>2007</year></element-citation></ref>
<ref id="b4-or-29-02-0445"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turksen</surname><given-names>K</given-names></name><name><surname>Troy</surname><given-names>TC</given-names></name></person-group><article-title>Junctions gone bad: claudins and loss of the barrier in cancer</article-title><source>Biochim Biophys Acta</source><volume>1816</volume><fpage>73</fpage><lpage>79</lpage><year>2011</year></element-citation></ref>
<ref id="b5-or-29-02-0445"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cereijido</surname><given-names>M</given-names></name><name><surname>Contreras</surname><given-names>RG</given-names></name><name><surname>Shoshani</surname><given-names>L</given-names></name><name><surname>Flores-Benitez</surname><given-names>D</given-names></name><name><surname>Larre</surname><given-names>I</given-names></name></person-group><article-title>Tight junction and polarity interaction in the transporting epithelial phenotype</article-title><source>Biochim Biophys Acta</source><volume>1778</volume><fpage>770</fpage><lpage>793</lpage><year>2008</year></element-citation></ref>
<ref id="b6-or-29-02-0445"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Katsuno</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>A</given-names></name></person-group><article-title>Tight junction-based epithelial microenvironment and cell proliferation</article-title><source>Oncogene</source><volume>27</volume><fpage>6930</fpage><lpage>6938</lpage><year>2008</year></element-citation></ref>
<ref id="b7-or-29-02-0445"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>TA</given-names></name><name><surname>Jiang</surname><given-names>WG</given-names></name></person-group><article-title>Loss of tight junction barrier function and its role in cancer metastasis</article-title><source>Biochim Biophys Acta</source><volume>1788</volume><fpage>872</fpage><lpage>891</lpage><year>2009</year></element-citation></ref>
<ref id="b8-or-29-02-0445"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchiando</surname><given-names>AM</given-names></name><name><surname>Graham</surname><given-names>WV</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name></person-group><article-title>Epithelial barriers in homeostasis and disease</article-title><source>Annu Rev Pathol</source><volume>5</volume><fpage>119</fpage><lpage>144</lpage><year>2010</year></element-citation></ref>
<ref id="b9-or-29-02-0445"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>TA</given-names></name><name><surname>Jiang</surname><given-names>WG</given-names></name></person-group><article-title>Tight junctions and their role in cancer metastasis</article-title><source>Histol Histopathol</source><volume>16</volume><fpage>1183</fpage><lpage>1195</lpage><year>2001</year></element-citation></ref>
<ref id="b10-or-29-02-0445"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullin</surname><given-names>JM</given-names></name><name><surname>Agostino</surname><given-names>N</given-names></name><name><surname>Rendon-Huerta</surname><given-names>E</given-names></name><name><surname>Thornton</surname><given-names>JJ</given-names></name></person-group><article-title>Keynote review: epithelial and endothelial barriers in human disease</article-title><source>Drug Discov Today</source><volume>10</volume><fpage>395</fpage><lpage>408</lpage><year>2005</year></element-citation></ref>
<ref id="b11-or-29-02-0445"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usami</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>F</given-names></name><etal/></person-group><article-title>Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus</article-title><source>Hum Pathol</source><volume>37</volume><fpage>569</fpage><lpage>577</lpage><year>2006</year></element-citation></ref>
<ref id="b12-or-29-02-0445"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornholdt</surname><given-names>J</given-names></name><name><surname>Friis</surname><given-names>S</given-names></name><name><surname>Godiksen</surname><given-names>S</given-names></name><etal/></person-group><article-title>The level of claudin-7 is reduced as an early event in colorectal carcinogenesis</article-title><source>BMC Cancer</source><volume>11</volume><fpage>65</fpage><year>2011</year></element-citation></ref>
<ref id="b13-or-29-02-0445"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>YS</given-names></name><name><surname>Tseng</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma</article-title><source>Hum Pathol</source><volume>41</volume><fpage>944</fpage><lpage>950</lpage><year>2010</year></element-citation></ref>
<ref id="b14-or-29-02-0445"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>T</given-names></name><name><surname>Kunisaki</surname><given-names>C</given-names></name><name><surname>Yoshihara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer</article-title><source>Oncol Rep</source><volume>19</volume><fpage>953</fpage><lpage>959</lpage><year>2008</year></element-citation></ref>
<ref id="b15-or-29-02-0445"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Choi</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma</article-title><source>Eur J Cancer</source><volume>47</volume><fpage>918</fpage><lpage>925</lpage><year>2011</year></element-citation></ref>
<ref id="b16-or-29-02-0445"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>MA</given-names></name><name><surname>Logullo</surname><given-names>AF</given-names></name><name><surname>Pasini</surname><given-names>FS</given-names></name><etal/></person-group><article-title>Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer</article-title><source>Oncol Rep</source><volume>27</volume><fpage>28</fpage><lpage>38</lpage><year>2012</year></element-citation></ref>
<ref id="b17-or-29-02-0445"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Oh</surname><given-names>TY</given-names></name><etal/></person-group><article-title>Up-regulated claudin 7 expression in intestinal-type gastric carcinoma</article-title><source>Oncol Rep</source><volume>18</volume><fpage>377</fpage><lpage>382</lpage><year>2007</year></element-citation></ref>
<ref id="b18-or-29-02-0445"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahiya</surname><given-names>N</given-names></name><name><surname>Becker</surname><given-names>KG</given-names></name><name><surname>Wood</surname><given-names>WH</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Morin</surname><given-names>PJ</given-names></name></person-group><article-title>Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion</article-title><source>PLoS One</source><volume>6</volume><fpage>e22119</fpage><year>2011</year></element-citation></ref>
<ref id="b19-or-29-02-0445"><label>19</label><element-citation publication-type="book"><collab>Cancer UICl</collab><source>TNM classification of malignant tumors</source><edition>5th edition</edition><publisher-name>Wiley-Less</publisher-name><publisher-loc>New York</publisher-loc><year>1997</year></element-citation></ref>
<ref id="b20-or-29-02-0445"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>E</given-names></name><name><surname>Kohama</surname><given-names>G</given-names></name><name><surname>Sunakawa</surname><given-names>H</given-names></name><name><surname>Iwai</surname><given-names>M</given-names></name><name><surname>Hiratsuka</surname><given-names>H</given-names></name></person-group><article-title>Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity</article-title><source>Cancer</source><volume>51</volume><fpage>2175</fpage><lpage>2180</lpage><year>1983</year></element-citation></ref>
<ref id="b21-or-29-02-0445"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshizawa</surname><given-names>K</given-names></name><name><surname>Nozaki</surname><given-names>S</given-names></name><name><surname>Kitahara</surname><given-names>H</given-names></name><etal/></person-group><article-title>Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines</article-title><source>Oncol Rep</source><volume>18</volume><fpage>987</fpage><lpage>991</lpage><year>2007</year></element-citation></ref>
<ref id="b22-or-29-02-0445"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshizawa</surname><given-names>K</given-names></name><name><surname>Nozaki</surname><given-names>S</given-names></name><name><surname>Okamune</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma</article-title><source>J Oral Pathol Med</source><volume>38</volume><fpage>535</fpage><lpage>539</lpage><year>2009</year></element-citation></ref>
<ref id="b23-or-29-02-0445"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taki</surname><given-names>M</given-names></name><name><surname>Kamata</surname><given-names>N</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Fujimoto</surname><given-names>R</given-names></name><name><surname>Tsutsumi</surname><given-names>S</given-names></name><name><surname>Nagayama</surname><given-names>M</given-names></name></person-group><article-title>Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells</article-title><source>Cancer Sci</source><volume>94</volume><fpage>593</fpage><lpage>597</lpage><year>2003</year></element-citation></ref>
<ref id="b24-or-29-02-0445"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashiri</surname><given-names>S</given-names></name><name><surname>Kumagai</surname><given-names>S</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>E</given-names></name></person-group><article-title>Development of a new invasion and metastasis model of human oral squamous cell carcinomas</article-title><source>Eur J Cancer B Oral Oncol</source><volume>31B</volume><fpage>216</fpage><lpage>221</lpage><year>1995</year></element-citation></ref>
<ref id="b25-or-29-02-0445"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nozaki</surname><given-names>S</given-names></name><name><surname>Endo</surname><given-names>Y</given-names></name><name><surname>Kawashiri</surname><given-names>S</given-names></name><etal/></person-group><article-title>Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis</article-title><source>Oral Oncol</source><volume>34</volume><fpage>58</fpage><lpage>62</lpage><year>1998</year></element-citation></ref>
<ref id="b26-or-29-02-0445"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conboy</surname><given-names>JG</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name><name><surname>Kan</surname><given-names>YW</given-names></name></person-group><article-title>Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells</article-title><source>Proc Natl Acad Sci USA</source><volume>85</volume><fpage>9062</fpage><lpage>9065</lpage><year>1988</year></element-citation></ref>
<ref id="b27-or-29-02-0445"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bello</surname><given-names>IO</given-names></name><name><surname>Vilen</surname><given-names>ST</given-names></name><name><surname>Niinimaa</surname><given-names>A</given-names></name><name><surname>Kantola</surname><given-names>S</given-names></name><name><surname>Soini</surname><given-names>Y</given-names></name><name><surname>Salo</surname><given-names>T</given-names></name></person-group><article-title>Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue</article-title><source>Hum Pathol</source><volume>39</volume><fpage>1212</fpage><lpage>1220</lpage><year>2008</year></element-citation></ref>
<ref id="b28-or-29-02-0445"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikenouchi</surname><given-names>J</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name></person-group><article-title>Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail</article-title><source>J Cell Sci</source><volume>116</volume><fpage>1959</fpage><lpage>1967</lpage><year>2003</year></element-citation></ref>
<ref id="b29-or-29-02-0445"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>LF</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells</article-title><source>Lab Invest</source><volume>92</volume><fpage>744</fpage><lpage>752</lpage><year>2012</year></element-citation></ref>
<ref id="b30-or-29-02-0445"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikami</surname><given-names>S</given-names></name><name><surname>Katsube</surname><given-names>K</given-names></name><name><surname>Oya</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis</article-title><source>Lab Invest</source><volume>91</volume><fpage>1443</fpage><lpage>1458</lpage><year>2011</year></element-citation></ref>
<ref id="b31-or-29-02-0445"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usami</surname><given-names>Y</given-names></name><name><surname>Satake</surname><given-names>S</given-names></name><name><surname>Nakayama</surname><given-names>F</given-names></name><etal/></person-group><article-title>Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression</article-title><source>J Pathol</source><volume>215</volume><fpage>330</fpage><lpage>339</lpage><year>2008</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-29-02-0445" position="float">
<label>Figure 1</label>
<caption>
<p>Immunohistochemical reactivity for claudin-7. (A) Strong expression of claudin-7 in normal tongue tissue as the positive control. (B) Mild expression of claudin-7 in grade 3 carcinoma as the positive assessment. (C) Weak expression of claudin-7 in grade 4C as the negative assessment. (D) No expression of claudin-7 in grade 4D as the negative assessment. Magnification, original &#x000D7;100.</p></caption>
<graphic xlink:href="OR-29-02-0445-g00.gif"/></fig>
<fig id="f2-or-29-02-0445" position="float">
<label>Figure 2</label>
<caption>
<p>Kaplan-Meier survival estimates for overall survival based on claudin-7 expression (P&lt;0.05).</p></caption>
<graphic xlink:href="OR-29-02-0445-g01.gif"/></fig>
<fig id="f3-or-29-02-0445" position="float">
<label>Figure 3</label>
<caption>
<p>Expressions of mRNA for, claudin-7, E-cadherin, Snail, &#x003B2;-actin in six cell lines. Aliquots (1 &#x003BC;g) of total RNAs were analyzed by reverse transcriptase-polymerase chain reaction.</p></caption>
<graphic xlink:href="OR-29-02-0445-g02.gif"/></fig>
<fig id="f4-or-29-02-0445" position="float">
<label>Figure 4</label>
<caption>
<p>Expressions of protein for Claudin-7, E-cadherin, Snail, &#x003B2;-actin in six cell lines. The protein samples (30 &#x003BC;g) that were extracted from the whole cellular structure were analyzed by western blotting.</p></caption>
<graphic xlink:href="OR-29-02-0445-g03.gif"/></fig>
<table-wrap id="tI-or-29-02-0445" position="float">
<label>Table I</label>
<caption>
<p>Yamamoto-Kohama classification.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Grade</th>
<th align="center" valign="bottom">Histologic grading</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Well-defined borderline</td></tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Cords, less marked borderline</td></tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Groups of cells, no distinct borderline</td></tr>
<tr>
<td align="left" valign="top">4C</td>
<td align="left" valign="top">Diffuse invasion, Cord-like type</td></tr>
<tr>
<td align="left" valign="top">4D</td>
<td align="left" valign="top">Diffuse invasion, Widespread type</td></tr></tbody></table></table-wrap>
<table-wrap id="tII-or-29-02-0445" position="float">
<label>Table II</label>
<caption>
<p>Clinicopathological parameters in relation to claudin-7 expression.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Parameter</th>
<th align="center" valign="bottom">Positive (&#x00025;)</th>
<th align="center" valign="bottom">Negative (&#x00025;)</th>
<th align="center" valign="bottom">Total</th></tr></thead>
<tbody>
<tr>
<td colspan="4" align="left" valign="top">Age, years</td></tr>
<tr>
<td align="left" valign="top">&#x02003;&#x02265;65</td>
<td align="center" valign="top">11 (47.8)</td>
<td align="center" valign="top">12 (52.2)</td>
<td align="center" valign="top">23</td></tr>
<tr>
<td align="left" valign="top">&#x02003;&lt;65</td>
<td align="center" valign="top">24 (54.5)</td>
<td align="center" valign="top">20 (45.5)</td>
<td align="center" valign="top">44</td></tr>
<tr>
<td colspan="4" align="left" valign="top">Gender</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Male</td>
<td align="center" valign="top">20 (52.6)</td>
<td align="center" valign="top">18 (47.4)</td>
<td align="center" valign="top">38</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Female</td>
<td align="center" valign="top">15 (51.7)</td>
<td align="center" valign="top">14 (48.3)</td>
<td align="center" valign="top">29</td></tr>
<tr>
<td colspan="4" align="left" valign="top">Tumor site</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Tongue</td>
<td align="center" valign="top">20 (51.3)</td>
<td align="center" valign="top">19 (49.7)</td>
<td align="center" valign="top">39</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Gingiva</td>
<td align="center" valign="top">6 (40.0)</td>
<td align="center" valign="top">9 (60.0)</td>
<td align="center" valign="top">15</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Oral floor</td>
<td align="center" valign="top">4 (80.0)</td>
<td align="center" valign="top">1 (20.0)</td>
<td align="center" valign="top">5</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Buccal</td>
<td align="center" valign="top">5 (71.4)</td>
<td align="center" valign="top">2 (28.6)</td>
<td align="center" valign="top">7</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Lip</td>
<td align="center" valign="top">0 (0.0)</td>
<td align="center" valign="top">1 (100.0)</td>
<td align="center" valign="top">1</td></tr>
<tr>
<td colspan="4" align="left" valign="top">T-category</td></tr>
<tr>
<td align="left" valign="top">&#x02003;T1</td>
<td align="center" valign="top">15 (75.0)</td>
<td align="center" valign="top">5 (25.0)</td>
<td align="center" valign="top">20<xref rid="tfn1-or-29-02-0445" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;T2</td>
<td align="center" valign="top">16 (48.5)</td>
<td align="center" valign="top">17 (51.5)</td>
<td align="center" valign="top">33<xref rid="tfn1-or-29-02-0445" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;T3</td>
<td align="center" valign="top">1 (25.0)</td>
<td align="center" valign="top">4 (75.0)</td>
<td align="center" valign="top">5<xref rid="tfn1-or-29-02-0445" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;T4</td>
<td align="center" valign="top">3 (33.3)</td>
<td align="center" valign="top">6 (66.7)</td>
<td align="center" valign="top">9<xref rid="tfn1-or-29-02-0445" ref-type="table-fn">a</xref></td></tr>
<tr>
<td colspan="4" align="left" valign="top">Lymph node metastasis</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Negative</td>
<td align="center" valign="top">30 (62.5)</td>
<td align="center" valign="top">18 (37.5)</td>
<td align="center" valign="top">48<xref rid="tfn2-or-29-02-0445" ref-type="table-fn">b</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;Positive</td>
<td align="center" valign="top">5 (26.3)</td>
<td align="center" valign="top">14 (73.7)</td>
<td align="center" valign="top">19<xref rid="tfn2-or-29-02-0445" ref-type="table-fn">b</xref></td></tr>
<tr>
<td colspan="4" align="left" valign="top">Differential type</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Well</td>
<td align="center" valign="top">25 (58.1)</td>
<td align="center" valign="top">18 (41.9)</td>
<td align="center" valign="top">43</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Moderately</td>
<td align="center" valign="top">9 (50.0)</td>
<td align="center" valign="top">9 (50.0)</td>
<td align="center" valign="top">18</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Poorly</td>
<td align="center" valign="top">1 (16.7)</td>
<td align="center" valign="top">5 (83.3)</td>
<td align="center" valign="top">6</td></tr>
<tr>
<td colspan="4" align="left" valign="top">Mode of invasion</td></tr>
<tr>
<td align="left" valign="top">&#x02003;1</td>
<td align="center" valign="top">11 (91.7)</td>
<td align="center" valign="top">1 (8.3)</td>
<td align="center" valign="top">12<xref rid="tfn3-or-29-02-0445" ref-type="table-fn">c</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;2</td>
<td align="center" valign="top">12 (75.0)</td>
<td align="center" valign="top">4 (25.0)</td>
<td align="center" valign="top">16<xref rid="tfn3-or-29-02-0445" ref-type="table-fn">c</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;3</td>
<td align="center" valign="top">9 (52.9)</td>
<td align="center" valign="top">8 (47.1)</td>
<td align="center" valign="top">17<xref rid="tfn3-or-29-02-0445" ref-type="table-fn">c</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;4C</td>
<td align="center" valign="top">3 (18.8)</td>
<td align="center" valign="top">13 (81.2)</td>
<td align="center" valign="top">16<xref rid="tfn3-or-29-02-0445" ref-type="table-fn">c</xref></td></tr>
<tr>
<td align="left" valign="top">&#x02003;4D</td>
<td align="center" valign="top">0 (0.0)</td>
<td align="center" valign="top">6 (100.0)</td>
<td align="center" valign="top">6<xref rid="tfn3-or-29-02-0445" ref-type="table-fn">c</xref></td></tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="center" valign="top">35 (52.2)</td>
<td align="center" valign="top">32 (47.8)</td>
<td align="center" valign="top">67</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-or-29-02-0445">
<label>a</label>
<p>p&lt;0.05,</p></fn><fn id="tfn2-or-29-02-0445">
<label>b</label>
<p>p&lt;0.01,</p></fn><fn id="tfn3-or-29-02-0445">
<label>c</label>
<p>p&lt;0.001.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tIII-or-29-02-0445" position="float">
<label>Table III</label>
<caption>
<p>Univariate and multivariate analyses for clinical parameters, claudin-7 expression in relation to overall survival of 67 patients with oral squamous cell carcinoma.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom" rowspan="3">Variables</th>
<th align="left" valign="bottom" rowspan="3">Clinical groups</th>
<th align="center" valign="bottom">Survivors</th>
<th align="center" valign="bottom">Non-survivors</th>
<th colspan="2" align="center" valign="bottom">Log rank</th>
<th align="center" valign="bottom">Cox regression</th>
<th align="center" valign="bottom" rowspan="3">Risk ratio (95&#x00025; CI)</th></tr>
<tr>
<th align="center" valign="bottom"/>
<th align="center" valign="bottom"/>
<th colspan="2" align="left" valign="bottom">
<hr/></th>
<th align="center" valign="bottom"/></tr>
<tr>
<th align="center" valign="bottom">n&#x0003D;43</th>
<th align="center" valign="bottom">n&#x0003D;24</th>
<th align="center" valign="bottom">&#x003C7;<sup>2</sup></th>
<th align="center" valign="bottom">p-value</th>
<th align="center" valign="bottom">p-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">T category</td>
<td align="left" valign="top">T3,4/T1,2</td>
<td align="right" valign="top">5/38</td>
<td align="center" valign="top">9/15</td>
<td align="right" valign="top">10.48</td>
<td align="center" valign="top">0.0012</td>
<td align="center" valign="top">NS</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">N category</td>
<td align="left" valign="top">N<sup>&#x0002B;</sup>/N0</td>
<td align="right" valign="top">8/35</td>
<td align="center" valign="top">11/13</td>
<td align="right" valign="top">8.79</td>
<td align="center" valign="top">0.0030</td>
<td align="center" valign="top">NS</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">Cell differentiation</td>
<td align="left" valign="top">Mod-poor/Well</td>
<td align="right" valign="top">12/31</td>
<td align="center" valign="top">12/12</td>
<td align="right" valign="top">5.63</td>
<td align="center" valign="top">0.018</td>
<td align="center" valign="top">NS</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">Mode of invasion</td>
<td align="left" valign="top">3-4D/1&#x02013;2</td>
<td align="right" valign="top">18/25</td>
<td align="center" valign="top">21/3</td>
<td align="right" valign="top">14.46</td>
<td align="center" valign="top">0.0001</td>
<td align="center" valign="top">0.0012</td>
<td align="center" valign="top">7.44 (2.221&#x02013;25.06)</td></tr>
<tr>
<td align="left" valign="top">Claudin-7</td>
<td align="left" valign="top">&#x0002B;/&#x02212;</td>
<td align="right" valign="top">27/16</td>
<td align="center" valign="top">8/16</td>
<td align="right" valign="top">6.67</td>
<td align="center" valign="top">0.0098</td>
<td align="center" valign="top">NS</td>
<td align="center" valign="top">NS</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn4-or-29-02-0445">
<p>NS, not significant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
